8 completed, 7 terminated, 3 unknown, 1 suspended. 10 Phase 1, 8 Phase 2, 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Terminated 6, Unknown 2, Completed 1, Withdrawn 1 |
| Phase 2 | 8 | Completed 5, Suspended 1, Terminated 1, Unknown 1 |
| Phase 3 | 5 | Completed 2, Suspended 1, Terminated 1, Unknown 1 |
Follow Agennix: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer talactoferrin, laboratory biomarker analysis - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Phase 1 | Terminated | Stanford University | 4 | 2012-05-01 | 2016-08-02 |
| Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies RGB-286638 - Hematological Malignancies | Phase 1 | Withdrawn | Agennix | 2011-11-01 | 2012-08-02 | |
| Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis Talactoferrin alfa, Placebo - Severe Sepsis | Phase 2 / Phase 3 | Suspended | Agennix | 1280 | 2011-06-01 | 2012-02-03 |
| Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants Talactoferrin, Placebo - Nosocomial Infections | Phase 1 / Phase 2 | Unknown | Agennix | 120 | 2009-06-01 | 2012-03-15 |
| Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer Talactoferrin, Placebo - Non Small Cell Lung Cancer | Phase 3 | Unknown | Agennix | 1100 | 2009-02-01 | 2012-03-15 |
| Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer Talactoferrin, Placebo - Non Small Cell Lung Cancer | Phase 3 | Completed | Agennix | 742 | 2008-11-01 | 2012-08-21 |
| Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis Talactoferrin alfa, Placebo - Severe Sepsis | Phase 2 | Completed | Agennix | 190 | 2008-04-01 | 2011-08-23 |
| Satraplatin and Vinorelbine in Advanced Solid Tumors Satraplatin in combo with vinorelbine - Advanced Solid Tumors | Phase 1 | Unknown | Southern Europe New Drug Organization | 27 | 2008-02-01 | 2010-10-13 |
| Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers Satraplatin, Abraxane - Advanced Cancers | Phase 1 | Completed | Yale University | 15 | 2007-05-01 | 2013-01-23 |
| A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Satraplatin plus radiation therapy - Prostate Cancer | Phase 1 | Terminated | Agennix | 2007-05-01 | 2012-03-23 | |
| Study of Satraplatin (JM-216) in Combination With Docetaxel satraplatin and docetaxel - Tumors | Phase 1 | Terminated | Agennix | 28 | 2007-03-01 | 2012-03-26 |
| Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) Oral Satraplatin - Prostate Cancer | Phase 3 | Terminated | Agennix | 344 | 2007-02-01 | 2012-08-17 |
| A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC) Erlotinib, Satraplatin - Lung Cancer | Phase 2 | Completed | Agennix | 100 | 2006-07-01 | 2012-08-07 |
| Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies satraplatin and capecitabine - Malignancies | Phase 1 | Terminated | Agennix | 24 | 2006-05-01 | 2012-03-23 |
| A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel Satraplatin - Tumors, Prostate Cancer | Phase 1 | Terminated | Agennix | 25 | 2006-03-01 | 2012-05-10 |
| Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer Satraplatin in combination with Paclitaxel - Non-small Cell Lung Cancer | Phase 2 | Completed | Agennix | 40 | 2005-12-01 | 2012-04-30 |
| Satraplatin for Patients With Metastatic Breast Cancer (MBC) Satraplatin - Metastatic Breast Cancer | Phase 2 | Completed | Agennix | 40 | 2005-11-01 | 2012-03-28 |
| Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma Recombinant Human Lactoferrin - Carcinoma, Renal Cell | Phase 2 | Completed | Agennix | 40 | 2004-09-01 | 2008-04-10 |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy Satraplatin - Carcinoma, Non-small Cell Lung, Lung Cancer | Phase 1 / Phase 2 | Terminated | Agennix | 20 | 2004-08-01 | 2012-08-17 |
| Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen Satraplatin, Prednisone - Prostate Cancer, Hormone Refractory Prostate Cancer | Phase 3 | Completed | Agennix | 2003-09-01 | 2012-08-07 |
Carcinoma, Non-Small-Cell Lung (6) · Neoplasms (4) · Prostatic Neoplasms (4) · Lung Neoplasms (2) · Sepsis (2) · Adenocarcinoma of Lung (1) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Breast Neoplasms (1) · Carcinoma, Renal Cell (1) · Cross Infection (1) · Hematologic Neoplasms (1) · Neoplasm Metastasis (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Tongue Neoplasms (1)
satraplatin (12) · talactoferrin alfa (6) · Albumin-Bound Paclitaxel (1) · Capecitabine (1) · Docetaxel (1) · Erlotinib Hydrochloride (1) · Paclitaxel (1) · Platinum (1) · Prednisone (1) · RGB 286638 (1) · Radiotherapy (1) · Vinorelbine (1)
United States (18) · Canada (4) · France (4) · Germany (4) · Spain (4) · United Kingdom (3) · Belgium (2) · Hungary (2) · Israel (2) · Italy (2) · Netherlands (2) · Poland (2) · Russia (2) · Argentina (1) · Australia (1)
Corey Langer, MD (1) · Cristiana Sessa, MD (1) · Ernest W. Yankee, Ph.D. (1) · George Wilding, MD (1) · Hari Deshpande, M.D. (1) · Heather Wakelee (1) · Howard Sandler, MD (1) · Joyce O'Shaughnessy, MD (1) · Kalpalatha K Guntupalli, MD (1) · Michael Petrone, MD (1) · Philippe Pultar, MD (1) · William Gradishar, MD (1)
PMID 23425819, PMID 23429330, PMID 26010687, PMID 27234409, PMID 27260839
R44HD057744 (1)